Live Breaking News & Updates on Therapeutics Clinical Research
Stay updated with breaking news from Therapeutics clinical research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA has set a target action date of December 16, 2023NDA supported by positive efficacy and safety data from the Phase 2 and pivotal Phase 3 trials of roflumilast foamIf approved, roflumilast foam. | April 18, 2023 ....
Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts - read this article along with other careers information, tips and advice on BioSpace ....